1
|
Sharma H, Kaushik M, Goswami P, Sreevani S, Chakraborty A, Ashique S, Pal R. Role of miRNAs in Brain Development. Microrna 2024; 13:MIRNA-EPUB-139520. [PMID: 38571343 DOI: 10.2174/0122115366287127240322054519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2023] [Revised: 02/09/2024] [Accepted: 02/21/2024] [Indexed: 04/05/2024]
Abstract
Non-coding RNAs that are small in size, called microRNAs (miRNAs), exert a conse-quence in neutralizing gene activity after transcription. The nervous system is a massively ex-pressed organ, and an expanding body of research reveals the vital functions that miRNAs play in the brain's growth and neural activity. The significant benefit of miRNAs on the development of the central nervous system is currently shown through new scientific methods that concentrate on targeting and eradicating vital miRNA biogenesis pathways the elements involving Dicer and DGCR8. Modulation of miRNA has been associated with numerous essential cellular processes on neural progenitors, like differentiation, proliferation, and destiny determination. Current re-search discoveries that emphasize the significance of miRNAs in the complex process of brain development are included in this book. The miRNA pathway plays a major role in brain devel-opment, its operational dynamics, and even diseases. Recent studies on miRNA-mediated gene regulation within neural discrepancy, the circadian period and synaptic remodeling are signs of this. We also discussed how these discoveries may affect our comprehension of the fundamental processes behind brain diseases, highlighting the novel therapeutic opportunities miRNAs pro-vide for treating various human illnesses.
Collapse
Affiliation(s)
- Himanshu Sharma
- Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad (UP), 244001, India
| | - Monika Kaushik
- Amity Institute of Pharmacy, Amity University Gwalior, 474005, Madhya Pradesh, India
| | - Priyanka Goswami
- Department of Pharmacognosy, Maharashtra Educational Society's H. K. College of Pharmacy, Mumbai, Maharashtra, 400102, India
| | - Sanakattula Sreevani
- Department of Pharmacology, Vivekananda college of pharmacy, Rajajinagar, Bengaluru, Karnataka, 560055, India
| | - Ananya Chakraborty
- Department of Biotechnology, Maulana Abul Kalam Azad University of Technology, West Bengal, 700064, India
| | - Sumel Ashique
- Department of Pharmaceutical Sciences, Bengal College of Pharmaceutical Sciences & Research, Durgapur, 713212, West Bengal, India
| | - Radheshyam Pal
- Department of Pharmaceutical Sciences, Bengal College of Pharmaceutical Sciences & Research, Durgapur, 713212, West Bengal, India
| |
Collapse
|
2
|
Agrawal A, Romics L, Thekkinkattil D, Soliman M, Kaushik M, Barmpounakis P, Mortimer C, Courtney CA, Goyal A, Garreffa E, Carmichael A, Lane RA, Rutherford C, Kim B, Achuthan R, Pitsinis V, Goh S, Ray B, Grover K, Vidya R, Murphy J. 'PartBreCon' study. A UK multicentre retrospective cohort study to assess outcomes following PARTial BREast reCONstruction with chest wall perforator flaps. Breast 2023; 71:82-88. [PMID: 37544090 PMCID: PMC10430575 DOI: 10.1016/j.breast.2023.07.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2023] [Revised: 06/27/2023] [Accepted: 07/11/2023] [Indexed: 08/08/2023] Open
Abstract
BACKGROUND Partial breast reconstruction with a pedicled chest wall perforator flap (CWPF) enables breast conservation in a higher tumour: breast volume ratio scenario. Since there is limited evidence, this retrospective cohort study aimed to ascertain immediate (30-days) and medium-term (follow-up duration) surgical outcomes. METHODS STROBE-compliant protocol ascertained CWPF outcomes between March 2011-March 2021. UK centres known to perform CWPF were invited to participate if they performed at least 10 cases. Data were retrospectively collected, including patient demographics, tumour and treatment characteristics, and surgical and oncological outcomes. Statistical analysis (R™) included multivariable logistic regression and sensitivity analysis. RESULTS Across 15 centres, 507 patients with median age (54 years, IQR; 48-62), body mass index (25.4 kg/m2, IQR; 22.5-29), tumour size (26 mm, IQR; 18-35), and specimen weight (62 g, IQR; 40-92) had following flap types: LiCAP (54.1%, n = 273), MiCAP/AiCAP (19.6%, n = 99), LiCAP + LTAP (19.8%, n = 100) and TDAP (2.2%, n = 11). 30-days complication rates were in 12%: haematoma (4.3%, n = 22), wound infection (4.3%, n = 22), delayed wound healing (2.8%, n = 14) and flap loss (0.6%, n = 3; 1 full) leading to readmissions (2.6%, n = 13) and re-operations (2.6%, n = 13). Positive margins (n = 88, 17.7%) led to 15.9% (n = 79) re-excisions, including 7.5% (n = 37) at the planned 2nd of 2-stage surgery and 1.8% (n = 9) mastectomy. At median 23 months (IQR; 11-39) follow-up, there were 1.2% (n = 6) symmetrisations; recurrences: local (1%), regional/nodal (0.6%) and distant (3.2%). CONCLUSIONS This large multicentre cohort study demonstrates acceptable complication and margin re-excision rates. CWPF extends the range of breast conservation techniques. Further studies are required for long-term oncological outcomes.
Collapse
Affiliation(s)
- A Agrawal
- Cambridge University Hospitals, Cambridge, UK.
| | - L Romics
- New Victoria Hospital, Glasgow, UK.
| | | | - M Soliman
- Cambridge University Hospitals, Cambridge, UK; Mansoura University, Egypt.
| | - M Kaushik
- University Hospitals of Leicester NHS Trust, Leicester, UK.
| | - P Barmpounakis
- Department of Statistics, Athens University of Economics and Business, Athens, Greece.
| | | | | | - A Goyal
- Royal Derby Hospital, Derby, UK.
| | | | - A Carmichael
- University Hospital of Derby and Burton, Belvedere Road, Burton on Trent, UK.
| | - R A Lane
- Cambridge University Hospitals, Cambridge, UK.
| | | | - B Kim
- St. James's University Hospital, Leeds, UK.
| | - R Achuthan
- St. James's University Hospital, Leeds, UK.
| | | | - S Goh
- Peterborough Hospital, Peterborough, UK.
| | - B Ray
- Harrogate NHS Trust, Harrogate, UK.
| | | | - R Vidya
- Royal Wolverhampton NHS Trust, Wolverhampton, UK.
| | - J Murphy
- Manchester University Hospital, Manchester, UK.
| |
Collapse
|
3
|
Neumann I, Patalay R, Kaushik M, Timlin H, Daniel C. Treatment of periocular lentigo maligna with topical 5% Imiquimod: a review. Eye (Lond) 2023; 37:408-414. [PMID: 35835989 PMCID: PMC9905524 DOI: 10.1038/s41433-022-02165-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2022] [Revised: 06/13/2022] [Accepted: 06/20/2022] [Indexed: 11/08/2022] Open
Abstract
Lentigo Maligna is a benign subtype of melanoma in situ and can progress to lentigo maligna melanoma, which is invasive. Complete surgical excision is the gold standard of treatment but requires large margins. If affecting the peri-ocular region, surgical excision leads to extensive defects, complex reconstructions, and functional impairment of the protection of the ocular surface. Here we review the reported literature about the use of Imiquimod 5% topical cream for lentigo maligna of the eyelid, the treatment outcomes, side effects and tolerance. In addition, the side effects of imiquimod treatment of non-LM lesions are described to help better inform the decision-making process. Treatment for peri-ocular Lentigo maligna showed a 56-86% complete treatment response and a 90% tolerability rate. However, reported treatment protocols vary and histopathological confirmation of clearance was only obtained in 56%. Further studies are required to determine the optimal treatment protocol to maximise clearance rates. Overall, Imiquimod was well tolerated in the peri-ocular area.
Collapse
Affiliation(s)
- Inga Neumann
- Adnexal Department, Moorfields Eye Hospital, London, UK.
| | - R Patalay
- Dermatology Department, Guys and St. Thomas Hospital, London, UK
| | - M Kaushik
- Adnexal Department, Moorfields Eye Hospital, London, UK
| | - H Timlin
- Adnexal Department, Moorfields Eye Hospital, London, UK
| | - C Daniel
- Adnexal Department, Moorfields Eye Hospital, London, UK
| |
Collapse
|
4
|
Awasthi A, Gulati M, Kumar B, Kaur J, Vishwas S, Khursheed R, Porwal O, Alam A, KR A, Corrie L, Kumar R, Kumar A, Kaushik M, Jha NK, Gupta PK, Chellappan DK, Gupta G, Dua K, Gupta S, Gundamaraju R, Rao PV, Singh SK. Recent Progress in Development of Dressings Used for Diabetic Wounds with Special Emphasis on Scaffolds. Biomed Res Int 2022; 2022:1659338. [PMID: 35832856 PMCID: PMC9273440 DOI: 10.1155/2022/1659338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/18/2021] [Revised: 05/19/2022] [Accepted: 06/08/2022] [Indexed: 11/17/2022]
Abstract
Diabetic wound (DW) is a secondary application of uncontrolled diabetes and affects about 42.2% of diabetics. If the disease is left untreated/uncontrolled, then it may further lead to amputation of organs. In recent years, huge research has been done in the area of wound dressing to have a better maintenance of DW. These include gauze, films, foams or, hydrocolloid-based dressings as well as polysaccharide- and polymer-based dressings. In recent years, scaffolds have played major role as biomaterial for wound dressing due to its tissue regeneration properties as well as fluid absorption capacity. These are three-dimensional polymeric structures formed from polymers that help in tissue rejuvenation. These offer a large surface area to volume ratio to allow cell adhesion and exudate absorbing capacity and antibacterial properties. They also offer a better retention as well as sustained release of drugs that are directly impregnated to the scaffolds or the ones that are loaded in nanocarriers that are impregnated onto scaffolds. The present review comprehensively describes the pathogenesis of DW, various dressings that are used so far for DW, the limitation of currently used wound dressings, role of scaffolds in topical delivery of drugs, materials used for scaffold fabrication, and application of various polymer-based scaffolds for treating DW.
Collapse
Affiliation(s)
- Ankit Awasthi
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India
| | - Monica Gulati
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India
- Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia
| | - Bimlesh Kumar
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India
| | - Jaskiran Kaur
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India
| | - Sukriti Vishwas
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India
| | - Rubiya Khursheed
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India
| | - Omji Porwal
- Department of Pharmacognosy, Faculty of Pharmacy, Tishk International University-Erbil, Kurdistan Region, Iraq
| | - Aftab Alam
- Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj, 11942 KSA, Saudi Arabia
| | - Arya KR
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India
| | - Leander Corrie
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India
| | - Rajan Kumar
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India
| | - Ankit Kumar
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India
| | - Monika Kaushik
- Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, Madhya Pradesh 474001, India
| | - Niraj Kumar Jha
- Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Plot No. 32-34 Knowledge Park III, Greater Noida, Uttar Pradesh 201310, India
| | - Piyush Kumar Gupta
- Department of Life Sciences, School of Basic Sciences and Research, Sharda University, Plot No. 32-34, Knowledge Park III, Greater Noida, 201310 Uttar Pradesh, India
- Department of Biotechnology, Graphic Era Deemed to be University, Dehradun, 248002 Uttarakhand, India
| | - Dinesh Kumar Chellappan
- Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000 Kuala Lumpur, Malaysia
| | - Gaurav Gupta
- School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, India
- Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India
- Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India
| | - Kamal Dua
- Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia
- Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, Australia
| | - Saurabh Gupta
- Chitkara College of Pharmacy, Chitkara University, Punjab, India
| | - Rohit Gundamaraju
- ER Stress and Mucosal Immunology Lab, School of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia 7248
| | - Pasupuleti Visweswara Rao
- Department of Biomedical Sciences and Therapeutics, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, 88400 Sabah, Malaysia
- Centre for International Relations and Research Collaborations, Reva University, Rukmini Knowledge Park, Rukmini Knowledge Park, Kattigenahili, Yelahanka, Bangalore, 560064, , Karnataka, India
| | - Sachin Kumar Singh
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India
- Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia
| |
Collapse
|
5
|
Chakrabarti A, Kaushik M, Khan J, Soota D, Ponnusamy K, Saini S, Manvati S, Singhal J, Ranganathan A, Pati S, Dhar PK, Singh S. tREPs-A New Class of Functional tRNA-Encoded Peptides. ACS Omega 2022; 7:18361-18373. [PMID: 35694484 PMCID: PMC9178612 DOI: 10.1021/acsomega.2c00661] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/01/2022] [Accepted: 05/13/2022] [Indexed: 06/15/2023]
Abstract
We asked if transfer RNA (tRNA) ever got an opportunity of translating its own sequence during evolution, what would have been the function of such tRNA-encoded peptides (tREPs)? If not, could one artificially synthesize tREPs to study the corresponding functional outcomes? Here, we report a novel, first-in-the-class, chemically synthesized tREP-18 molecule originating from the Escherichia coli tRNA sequence showing potent antileishmanial property. As a first step, E. coli tRNAs were computationally translated into peptide sequence equivalents and a database of full-length hypothetical tREPs was created. The tREP sequences were sent into sequence, structure, and energy filters to narrow down potential peptides for experimental validation. Based on the functional predictions, tREPs were screened against antiparasitic targets, leading to the identification of tREP-18 as a potential antiparasitic peptide. The in vitro assay of chemically synthesized tREP-18 on the Ag83 strain of Leishmania donovani showed its potent antileishmanial property (IC50 value of 22.13 nM). The atomic force microscopy and scanning electron microscopy images indicated significant alteration in the cytoskeletal architecture of tREP-18-treated parasites. Also, tREP-18 seems to destabilize the mitochondrial membrane potential of parasites, disrupting their cellular integrity and leading to parasitic death. The cellular assays of the tREP-18 peptide on the BS12 strain, a clinical isolate of post-kala azar dermal leishmaniasis, demonstrated its significant efficacy at an IC50 value of 15 nM. The tREP-18 peptide showed a toxic effect on the amastigote stage of the parasite, showing macrophage pathogen clearance at a concentration of 22.5 nM. This study provides the proof of the concept of making a new class of functional peptides from tRNA sequences. It also opens a huge untapped tRNA-peptide space toward novel discoveries and applications. In the future, it would be interesting to perform tREP edits and redesign tREPs toward specific applications.
Collapse
Affiliation(s)
- Amrita Chakrabarti
- Department of Life Sciences, Shiv Nadar University, Greater Noida 201314, Uttar Pradesh, India
- Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi 110067, India
| | - Monika Kaushik
- School of Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India
| | - Juveria Khan
- School of Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India
| | - Deepanshu Soota
- National Centre for Biological Sciences, Bangalore 560065, India
| | | | - Sunil Saini
- Department of Biophysics, All India Institute of Medical Sciences, New Delhi 110029, India
| | - Siddharth Manvati
- School of Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India
| | - Jhalak Singhal
- Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi 110067, India
| | - Anand Ranganathan
- Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi 110067, India
| | - Soumya Pati
- Department of Life Sciences, Shiv Nadar University, Greater Noida 201314, Uttar Pradesh, India
| | - Pawan Kumar Dhar
- School of Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India
- Special Centre for Systems Medicine, Jawaharlal Nehru University, New Delhi 110067, India
| | - Shailja Singh
- Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi 110067, India
| |
Collapse
|
6
|
Chandarana M, Kohli P, Gaber A, Kaushik M. Immediate pre-pectoral breast reconstruction using acellular dermal matrix - Results from a single centre from United Kingdom. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.03.165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
7
|
Sengupta S, Handoo A, Mehta S, Kaushik M. T105 POCT in critical care: An accuracy check! Clin Chim Acta 2022. [DOI: 10.1016/j.cca.2022.04.573] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
8
|
Chauhan KS, Das A, Jaiswal H, Saha I, Kaushik M, Patel VK, Tailor P. IRF8 and BATF3 interaction enhances the cDC1 specific Pfkfb3 gene expression. Cell Immunol 2021; 371:104468. [PMID: 34968772 DOI: 10.1016/j.cellimm.2021.104468] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2021] [Revised: 11/27/2021] [Accepted: 11/28/2021] [Indexed: 11/03/2022]
Abstract
Dendritic cells (DCs) play central role in innate as well as adaptive immune responses regulated by diverse DC subtypes that vary in terms of surface markers, transcriptional profile and functional responses. Generation of DC diversity from progenitor stage is tightly regulated by complex molecular inter-play between transcription factors. We earlier demonstrated that Batf3 and Id2 expression have a synergistic effect on the Irf8 directed classical cDC1 development. In present study, Bi-molecular fluorescence complementation assay suggested that IRF8 interacts with BATF3, and ID2 may aid cDC1 development independently. Genome wide recruitment analysis of IRF8 and BATF3 from different DC subtypes led to identification of the overlapping regions of occupancy by these two transcription factors. Further analysis of overlapping peaks of IRF8 and BATF3 occupancy in promoter region within the cDC1 subtype specific transcriptional pattern identified a metabolically important Pfkfb3 gene. Among various immune cell types; splenic cDC1 subtype displayed enhanced expression of Pfkfb3. Analysis of Irf8-/-, Irf8R294C and Batf3DCKO DC confirmed direct regulation of Pfkfb3 enhanced expression specifically in cDC1 subtype. Further we show that inhibition of PFKFB3 enzymatic activity by a chemical agent PFK15 led to reduction in cDC1 subtype in both in vitro FLDC cultures as well as in vivo mouse spleens. Together, our study identified the direct regulation of cDC1 specific enhanced expression of Pfkfb3 in glycolysis and cDC1 biology.
Collapse
Affiliation(s)
- Kuldeep Singh Chauhan
- Laboratory of Innate Immunity, National Institute of Immunology, New Delhi, India; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA(1)
| | - Annesa Das
- Laboratory of Innate Immunity, National Institute of Immunology, New Delhi, India
| | - Hemant Jaiswal
- Laboratory of Innate Immunity, National Institute of Immunology, New Delhi, India; Laboratory of Molecular Immunology, National Institute of Allergy and, Infectious Diseases, National Institutes of Health, Bethesda, MD, USA(2)
| | - Irene Saha
- Laboratory of Innate Immunity, National Institute of Immunology, New Delhi, India; Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA(3)
| | - Monika Kaushik
- Laboratory of Innate Immunity, National Institute of Immunology, New Delhi, India; School of Biotechnology, Jawaharlal Nehru University, New Delhi, India(4)
| | | | - Prafullakumar Tailor
- Laboratory of Innate Immunity, National Institute of Immunology, New Delhi, India; Special Centre for Systems Medicine (SCSM), Jawaharlal Nehru University, New Delhi, India.
| |
Collapse
|
9
|
Gaber A, Sardar M, Iqbal J, Ansari A, Al-Attar M, Kaushik M. P085. Can ultrasound be omitted in the assessment of patients presenting with suspicion of implant rupture? Eur J Surg Oncol 2021. [DOI: 10.1016/j.ejso.2021.03.089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
10
|
Gaber A, Sardar M, Al-Attar M, Kaushik M. P058. Radiofrequency identification (RFID) tag localisation of non-palpable breast lesions: Early experience in a large university hospital. Eur J Surg Oncol 2021. [DOI: 10.1016/j.ejso.2021.03.062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
11
|
Agrawal A, Romics L, Thekkinkattil D, Kaushik M, Mortimer C, Courtney CA, Goyal A, Garreffa E, Carmichael A, Hamad A, Lane R, Blackhall V, Rutherford C, Pitsinis V, Goh S, Ray B, Grover K, Mansell J, Vidya R, Murphy J. 24. Partial breast reconstruction with chest wall perforator flaps - Initial data from 'partbrerecon' collaborative. Eur J Surg Oncol 2021. [DOI: 10.1016/j.ejso.2021.03.220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
12
|
Kaushik M, Manvati S, Khan J, Verma N, Dhar PK. Corrigendum to "Association of miR-760 with cancer: An overview" [Gene 747 (2020) 144648]. Gene 2021; 782:145570. [PMID: 33757673 DOI: 10.1016/j.gene.2021.145570] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
- Monika Kaushik
- School of Biotechnology, Jawaharlal Nehru University, New Mehrauli Road, New Delhi 110067, India
| | - Siddharth Manvati
- School of Biotechnology, Jawaharlal Nehru University, New Mehrauli Road, New Delhi 110067, India
| | - Juveria Khan
- School of Biotechnology, Jawaharlal Nehru University, New Mehrauli Road, New Delhi 110067, India
| | - Neeraj Verma
- School of Biotechnology, Jawaharlal Nehru University, New Mehrauli Road, New Delhi 110067, India
| | - Pawan K Dhar
- School of Biotechnology, Jawaharlal Nehru University, New Mehrauli Road, New Delhi 110067, India.
| |
Collapse
|
13
|
Kaushik M, Nehra A, Gill S, Gill R. Unraveling the multifaceted histone chaperone RbAp46/48 in Plasmodium falciparum. Int J Infect Dis 2020. [DOI: 10.1016/j.ijid.2020.09.1109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
14
|
Gaber A, Al-Attar M, Pilgrim S, Hoosein M, Kaushik M. Outcomes of Magseed localisation of non-palpable breast lesions in a large university hospital. Eur J Cancer 2020. [DOI: 10.1016/s0959-8049(20)30633-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
15
|
Jarral K, Kancherla K, Arif Z, Sharma S, Kaushik M. Assessing the benefits and toxicities of platinum containing neoadjuvant chemotherapy in triple negative breast cancer. Eur J Cancer 2020. [DOI: 10.1016/s0959-8049(20)30677-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
16
|
Mullapudi NA, Laws S, Kaushik M, Harvey J, Sircar T, Michalak S, Vidya R. 06. SENTINEL LYMPH NODE IDENTIFICATION USING SUPER PARAMAGNETIC IRON OXIDE VERSUS RADIOISOTOPE: THE UK SENTIMAG TRIAL (SMART STUDY). Eur J Surg Oncol 2020. [DOI: 10.1016/j.ejso.2020.03.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
17
|
Saha I, Jaiswal H, Mishra R, Nel HJ, Schreuder J, Kaushik M, Singh Chauhan K, Singh Rawat B, Thomas R, Naik S, Kumar H, Tailor P. RelB suppresses type I Interferon signaling in dendritic cells. Cell Immunol 2020; 349:104043. [PMID: 32044112 DOI: 10.1016/j.cellimm.2020.104043] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2019] [Revised: 12/23/2019] [Accepted: 01/10/2020] [Indexed: 10/25/2022]
Abstract
Type I Interferon (IFN) signaling plays a critical role in dendritic cell (DC) development and functions. Inhibition of hyper type I IFN signaling promotes cDC2 subtype development. Relb is essential to development of cDC2 subtype and here we analyzed its effect on type I IFN signaling in DCs. We show that Relb suppresses the homeostatic type I IFN signaling in cDC2 cultures. TLR stimulation of FL-DCs led to RelB induction coinciding with fall in IFN signatures; conforming with the observation Relb expression reduced TLR stimulated IFN induction along with decrease in ISGs. Towards understanding mechanism, we show that effects of RelB are mediated by increased levels of IκBα. We demonstrate that RelB dampened antiviral responses by lowering ISG levels and the defect in cDC2 development in RelB null mice can be rescued in Ifnar1-/- background. Overall, we propose a novel role of RelB as a negative regulator of the type I IFN signaling pathway; fine tuning development of cDC2 subtype.
Collapse
Affiliation(s)
- Irene Saha
- Laboratory of Innate Immunity, National Institute of Immunology, New Delhi, India
| | - Hemant Jaiswal
- Laboratory of Innate Immunity, National Institute of Immunology, New Delhi, India
| | - Richa Mishra
- Department of Biological Sciences, Laboratory of Immunology and Infectious Disease Biology, Indian Institute of Science Education and Research (IISER) Bhopal, Bhopal 462066, India
| | - Hendrik J Nel
- The University of Queensland Diamantina Institute, Faculty of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia
| | - Jaring Schreuder
- Molecular Medicine Division, Walter and Eliza Hall Institute, Parkville, VIC 3052, Australia
| | - Monika Kaushik
- Laboratory of Innate Immunity, National Institute of Immunology, New Delhi, India
| | | | | | - Ranjeny Thomas
- The University of Queensland Diamantina Institute, Faculty of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia
| | - Shalin Naik
- Molecular Medicine Division, Walter and Eliza Hall Institute, Parkville, VIC 3052, Australia
| | - Himanshu Kumar
- Department of Biological Sciences, Laboratory of Immunology and Infectious Disease Biology, Indian Institute of Science Education and Research (IISER) Bhopal, Bhopal 462066, India
| | - Prafullakumar Tailor
- Laboratory of Innate Immunity, National Institute of Immunology, New Delhi, India.
| |
Collapse
|
18
|
Manvati S, Mangalhara KC, Kalaiarasan P, Chopra R, Agarwal G, Kumar R, Saini SK, Kaushik M, Arora A, Kumari U, Bamezai RNK, Dhar PK. miR-145 supports cancer cell survival and shows association with DDR genes, methylation pattern, and epithelial to mesenchymal transition. Cancer Cell Int 2019; 19:230. [PMID: 31516387 PMCID: PMC6731614 DOI: 10.1186/s12935-019-0933-8] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2018] [Accepted: 08/18/2019] [Indexed: 12/12/2022] Open
Abstract
Background Despite several reports describing the dual role of miR-145 as an oncogene and a tumor suppressor in cancer, not much has been resolved and understood. Method In this study, the potential targets of miR-145 were identified bio-informatically using different target prediction tools. The identified target genes were validated in vitro by dual luciferase assay. Wound healing and soft agar colony assay assessed cell proliferation and migration. miR-145 expression level was measured quantitatively by RT-PCR at different stages of breast tumor. Western blot was used to verify the role of miR-145 in EMT transition using key marker proteins. Result Wound healing and soft agar colony assays, using miR-145 over-expressing stably transfected MCF7 cells, unraveled its role as a pro-proliferation candidate in cancerous cells. The association between miR-145 over-expression and differential methylation patterns in representative target genes (DR5, BCL2, TP53, RNF8, TIP60, CHK2, and DCR2) supported the inference drawn. These in vitro observations were validated in a representative set of nodal positive tumors of stage 3 and 4 depicting higher miR-145 expression as compared to early stages. Further, the role of miR-145 in epithelial-mesenchymal (EMT) transition found support through the observation of two key markers, Vimentin and ALDL, where a positive correlation with Vimentin protein and a negative correlation with ALDL mRNA expression were observed. Conclusion Our results demonstrate miR-145 as a pro-cancerous candidate, evident from the phenotypes of aggressive cellular proliferation, epithelial to mesenchymal transition, hypermethylation of CpG sites in DDR and apoptotic genes and upregulation of miR-145 in later stages of tumor tissues.
Collapse
Affiliation(s)
- Siddharth Manvati
- 1School of Biotechnology, Jawaharlal Nehru University, New Delhi, India
| | - Kailash Chandra Mangalhara
- 2National Centre of Applied Human Genetics, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India
| | | | - Rupali Chopra
- 2National Centre of Applied Human Genetics, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India
| | - Gaurav Agarwal
- 3Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
| | - Rakesh Kumar
- 4School of Biotechnology, Shri Mata Vaishno Devi University, Kakryal, Katra, Jammu and Kashmir India
| | - Sunil Kumar Saini
- 1School of Biotechnology, Jawaharlal Nehru University, New Delhi, India
| | - Monika Kaushik
- 1School of Biotechnology, Jawaharlal Nehru University, New Delhi, India
| | - Ankita Arora
- 1School of Biotechnology, Jawaharlal Nehru University, New Delhi, India
| | - Usha Kumari
- 5Faculty of Medicine, AIMST University, Bedong, Malaysia
| | - Rameshwar Nath Koul Bamezai
- 2National Centre of Applied Human Genetics, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India
| | - Pawan Kumar Dhar
- 1School of Biotechnology, Jawaharlal Nehru University, New Delhi, India
| |
Collapse
|
19
|
Padmanabhan A, Kaushik M, Niranjan R, Richards JS, Ebright B, Venkatasubbu GD. Zinc Oxide nanoparticles induce oxidative and proteotoxic stress in ovarian cancer cells and trigger apoptosis Independent of p53-mutation status. Appl Surf Sci 2019; 487:807-818. [PMID: 32042215 PMCID: PMC7009796 DOI: 10.1016/j.apsusc.2019.05.099] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/09/2023]
Abstract
Ovarian cancer continues to be the most lethal among gynecological malignancies and the major cause for cancer-associated mortality among women. Limitations of current ovarian cancer therapeutics is highlighted by the high frequency of drug-resistant recurrent tumors and the extremely poor 5-year survival rates. Zinc oxide nanoparticles (ZnO-NPs) have shown promise in various biomedical applications including utility as anti-cancer agents. Here, we describe the synthesis and characterization of physical properties of ZnO-NPs of increasing particle size (15 nm - 55 nm) and evaluate their benefits as an ovarian cancer therapeutic using established human ovarian cancer cell lines. Our results demonstrate that the ZnO-NPs induce acute oxidative and proteotoxic stress in ovarian cancer cells leading to their death via apoptosis. The cytotoxic effect of the ZnO-NPs was found to increase slightly with a decrease in nanoparticle size. While ZnO-NPs caused depletion of both wild-type and gain-of-function (GOF) mutant p53 protein in ovarian cancer cells, their ability to induce apoptosis was found to be independent of the p53-mutation status in these cells. Taken together, these results highlight the potential of ZnO-NPs to serve as an anti-cancer therapeutic agent for treating ovarian cancers independent of the p53 mutants of the cancer cells.
Collapse
Affiliation(s)
- Achuth Padmanabhan
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX. 77030. USA
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX. 77030. USA
- Center for Reproductive Medicine, Baylor College of Medicine, Houston, TX. 77030. USA
- Co-corresponding authors
| | - M Kaushik
- Department of Nanotechnology, SRM Institute of Science and Technology, Tamil Nadu. 603203. India
| | - R Niranjan
- Department of Nanotechnology, SRM Institute of Science and Technology, Tamil Nadu. 603203. India
| | - JoAnne S Richards
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX. 77030. USA
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX. 77030. USA
- Center for Reproductive Medicine, Baylor College of Medicine, Houston, TX. 77030. USA
| | - Brandon Ebright
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX. 77030. USA
| | - G Devanand Venkatasubbu
- Department of Nanotechnology, SRM Institute of Science and Technology, Tamil Nadu. 603203. India
- Co-corresponding authors
| |
Collapse
|
20
|
Niranjan R, Kaushik M, Selvi RT, Prakash J, Venkataprasanna KS, Prema D, Pannerselvam B, Venkatasubbu GD. PVA/SA/TiO 2-CUR patch for enhanced wound healing application: In vitro and in vivo analysis. Int J Biol Macromol 2019; 138:704-717. [PMID: 31344412 DOI: 10.1016/j.ijbiomac.2019.07.125] [Citation(s) in RCA: 35] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2019] [Revised: 07/04/2019] [Accepted: 07/21/2019] [Indexed: 12/15/2022]
Abstract
Wound healing is a complex multistep process. Wound healing materials should have good antibacterial activity against wound infection causing microbes. Curcumin has effective antimicrobial activity, anti-inflammatory and antioxidant property. Titanium dioxide (TiO2) is a biocompatible, nontoxic material used for many biomedical applications. The Usage of curcumin tagged TiO2 nanoparticles for wound healing activity is promising due to the properties of both curcumin and TiO2. We have synthesized curcumin tagged TiO2 nanoparticles. The synthesized materials are characterized with XRD, FTIR and TEM. TiO2-Cur nanocomposite was incorporated into poly vinyl alcohol (PVA) and sodium alginate (SA) patch. The PVA/SA/TiO2-Cur patch was prepared by gel casting method. Antibacterial efficiency of PVA/SA/TiO2-Cur patch was analyzed. Further, in vivo studies conducted on Wister rats confirmed the enhanced wound healing property of the PVA/SA/TiO2-Cur patch. Our results suggest that this could be an ideal biomaterial for wound dressing applications.
Collapse
Affiliation(s)
- R Niranjan
- Department of Nanotechnology, SRM Institute of Science and Technology, Tamil Nadu, India
| | - M Kaushik
- Department of Nanotechnology, SRM Institute of Science and Technology, Tamil Nadu, India
| | - R Thamarai Selvi
- Department of Physics, SRM Institute of Science and Technology, Tamil Nadu, India
| | - J Prakash
- Department of Nanotechnology, SRM Institute of Science and Technology, Tamil Nadu, India
| | - K S Venkataprasanna
- Department of Nanotechnology, SRM Institute of Science and Technology, Tamil Nadu, India
| | - D Prema
- Department of Nanotechnology, SRM Institute of Science and Technology, Tamil Nadu, India
| | - Balashanmugam Pannerselvam
- Centre for Human & Organizational Resources Development (CHORD), CSIR- Central Leather Research Institute, Chennai, Tamil Nadu, India
| | | |
Collapse
|
21
|
Eichler C, Paepke S, Ohlinger R, Mathias W, Scheffen I, Lux M, Hadad S, Kiernan T, Whisker L, Kaushik M, King P. Abstract P2-14-05: Can an internal surgical adhesive facilitate drain-free mastectomy and reduce overall invasiveness?-A prospective, randomized, controlled, multicenter non-inferiority trial. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p2-14-05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction: Mastectomy closure without drains has many potential advantages. Flap fixation techniques have shown to be an effective alternative to drains. This study tested the non-inferiority of a surgical adhesive in overall invasiveness compared to standard wound closure with drains. Methods: This trial (ClinicalTrials.gov Identifier: NCT02958449) recruited seventy-seven patients undergoing eighty-four mastectomies +/- SLNB (n=84) at eleven international centers. Procedures were prospectively randomized to standard wound closure with drains (SWC; n=41) or wound closure without drains using a high strength lysine-based adhesive named TissuGlu® (TG; n= 43). The primary outcome measured assessed overall invasiveness using the number of post-operative clinical interventions, including drain removals and needle aspirations. Secondary endpoints included total wound drainage, cumulative days of treatment, days to drain removal and wound healing related complications. A patient questionnaire evaluating quality of life measures was also administered. Results: Subjects in the TissuGlu® group required significantly fewer post-operative clinical interventions (1.25 ± 1.39 TG vs. 2.03 ± 1.45 SWC, p = <.0001) compared to the Control group and had fewer cumulative days of treatment (defined as days of drains being in place and / or days on which an aspiration occurred; 2.14 ± 4.15 TG vs. 5.76 ± 4.02 SWC, p = <0.0001). Presence of a drain was associated with significantly higher pain and lower mobility scores. Conclusion: The study demonstrates that flap fixation with this adhesive can permit drain-free mastectomy closure, reducing overall invasiveness and patient morbidity.
Citation Format: Eichler C, Paepke S, Ohlinger R, Mathias W, Scheffen I, Lux M, Hadad S, Kiernan T, Whisker L, Kaushik M, King P. Can an internal surgical adhesive facilitate drain-free mastectomy and reduce overall invasiveness?-A prospective, randomized, controlled, multicenter non-inferiority trial [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P2-14-05.
Collapse
Affiliation(s)
- C Eichler
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - S Paepke
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - R Ohlinger
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - W Mathias
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - I Scheffen
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - M Lux
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - S Hadad
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - T Kiernan
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - L Whisker
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - M Kaushik
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - P King
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| |
Collapse
|
22
|
Puri S, Sharma N, Newcombe R, Kaushik M, Al-Attar M, Pascaline S, Hajaj M, Wallis M, Elsberger B, Goyal A. Axillary tumour burden in women with one abnormal node on ultrasound compared to women with multiple abnormal nodes. Clin Radiol 2018; 73:391-395. [DOI: 10.1016/j.crad.2017.12.014] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2017] [Accepted: 12/14/2017] [Indexed: 11/27/2022]
|
23
|
Yadav M, Kaushik M, Sharma R, Chowdry P. MINIMAL INVASIVE SURGICAL APPROACH IN THEMANAGEMENT OF COMMINUTED CROWN-ROOT FRACTURE- A CASE REPORT. J West Afr Coll Surg 2017; 7:128-140. [PMID: 30479995 PMCID: PMC6237318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Comminuted root fractures have a questionable prognosis and present with limited treatment options. In the following case, a comminuted crown root fracture in relation to maxillary left central incisor was managed with a minimally invasive surgical approach. The procedure involved repairing the multiple fracture lines in the root with Biodentine following the endodontic therapy and root resection. The patient was found to be asymptomatic at the end of a follow up period of ten months.
Collapse
Affiliation(s)
- M Yadav
- Department of Conservative Dentistry and Endodontics, Army College of Dental Sciences, Jai Jawahar Nagar, Chennapur, Secunderabad, Telangana, India
| | - M Kaushik
- Department of Conservative Dentistry and Endodontics, Army College of Dental Sciences
| | - R Sharma
- Department of Conservative Dentistry and Endodontics, Army College of Dental Sciences
| | - P Chowdry
- Department of Conservative Dentistry and Endodontics, Army College of Dental Sciences
| |
Collapse
|
24
|
Manvati S, Mangalhara KC, Khan J, Pathania GL, Kaul S, Kaushik M, Arora A, Dhar PK. Deciphering the role of microRNA - A step by step guide. Gene Expr Patterns 2017; 25-26:59-65. [PMID: 28603023 DOI: 10.1016/j.gep.2017.06.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2017] [Revised: 05/03/2017] [Accepted: 06/06/2017] [Indexed: 10/19/2022]
Abstract
MicroRNAs (miRNAs), are small non-coding RNAs of approximately 22 nucleotides in length, playing an important role in regulating gene expression post-transcriptionally. Understanding the effect of miRNA regulation in a pathway-specific manner unravels the approaches adopted to apprehend biological mechanisms, the information, which is scanty for researchers, not primed already for miR related research. Here, we describe a quick perspective in 5 steps with probable approaches and assays at every level to unravel the specific role of a microRNA, miR-145a-5p, as an example. This perspective as a guide would help in identifying novel targets for a microRNA, as shown for miR-145a-5p, which down-regulated the mRNA expression of ADD3 and BRCA2, using bioinformatic tools and experimental assays.
Collapse
Affiliation(s)
- Siddharth Manvati
- School of Biotechnology, Jawaharlal Nehru University, New Mehrauli Road, Saraswatipuram, New Delhi 110067, India.
| | - Kailash Chandra Mangalhara
- National Centre of Applied Human Genetics, School of Life Sciences, Jawaharlal Nehru University, New Mehrauli Road, Saraswatipuram, New Delhi 110067, India
| | - Juveria Khan
- School of Biotechnology, Jawaharlal Nehru University, New Mehrauli Road, Saraswatipuram, New Delhi 110067, India
| | - Geeta Lal Pathania
- National Centre of Applied Human Genetics, School of Life Sciences, Jawaharlal Nehru University, New Mehrauli Road, Saraswatipuram, New Delhi 110067, India
| | - Srishti Kaul
- Northeastern University - College of Professional Studies, 360 Huntington Avenue, Boston, MA 02215, United States
| | - Monika Kaushik
- School of Biotechnology, Jawaharlal Nehru University, New Mehrauli Road, Saraswatipuram, New Delhi 110067, India
| | - Ankita Arora
- School of Biotechnology, Jawaharlal Nehru University, New Mehrauli Road, Saraswatipuram, New Delhi 110067, India
| | - Pawan K Dhar
- School of Biotechnology, Jawaharlal Nehru University, New Mehrauli Road, Saraswatipuram, New Delhi 110067, India
| |
Collapse
|
25
|
Kaushik M, Yadav M. MARGINAL MICROLEAKAGE PROPERTIES OF ACTIVA BIOACTIVE RESTORATIVE AND NANOHYBRID COMPOSITE RESIN USING TWO DIFFERENT ADHESIVES IN NON CARIOUS CERVICAL LESIONS - AN IN VITRO STUDY. J West Afr Coll Surg 2017; 7:1-14. [PMID: 29951462 PMCID: PMC6016748] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
BACKGROUND In clinical practice, the restoration of non-carious cervical lesions is a challenge, because most of the time the cervical margin is located in cementum or dentin. This characteristic makes the cervical margin more susceptible to microleakage, causing cavosurface stains, postoperative sensitivity and also favours the incidence of carious lesions. AIM To compare and evaluate the microleakage in class V lesions restored with Activa Bioactive restorative and nanohybrid composite resin using two different bonding agents. METHODOLOGY In this study, 50 class V cavities were prepared in freshly extracted teeth. The samples were randomly divided into 5 groups (n=10), depending on the type of restorative material and bonding agent: Group 1 - Activa Bioactive (Pulpdent, USA) + No bonding, Group 2 - Activa Bioactive + Tetric N Bond (Ivoclar Vivadent, Colombia),Group 3 - Activa Bioactive + G Bond (GC Corp., Tokyo, Japan), Group 4 - Nanohybrid Composite (Ivoclar Vivadent, Colombia) + Tetric N Bond, Group 5 - Nanohybrid Composite + G Bond. The samples were restored with their respective material based on the group. After curing all the specimens were subjected to thermocycling and cyclic loading. Specimens were stained with 2% rhodamin b dye and evaluated for dye penetration. RESULTS Results were obtained based on Kruskal Wallis and Mann Whitney U- test. CONCLUSION Within the limitations of this study, none of the materials were free from microleakage. All the materials showed more microleakage at gingival margins compared to occlusal margins. Among all the groups Activa Bioactive restorative when used in combination with Tetric N Bond showed the least microleakage.
Collapse
Affiliation(s)
- M Kaushik
- Department of Conservative Dentistry and Endodontics, Army College of Dental Sciences, Secunderabad, Telangana 500087, India
| | - M Yadav
- Department of Conservative Dentistry and Endodontics, Army College of Dental Sciences, Secunderabad, Telangana 500087, India
| |
Collapse
|
26
|
Deepthi V, V I Nair V, Thomas V, Raj N, P Ramakrishnan S, Khan J, Kaushik M, K Dhar P, S Nair A. Function annotation of peptides generated from the non-coding regions of D. melanogaster genome. Bioinformation 2017; 12:202-208. [PMID: 28149056 PMCID: PMC5267965 DOI: 10.6026/97320630012202] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2016] [Revised: 05/25/2016] [Accepted: 05/25/2016] [Indexed: 11/23/2022] Open
Abstract
De novo emergence of genes is the most fundamental form of genetic diversity that is attracting the attention of the scientific
community. Identification of short open reading frames (sORFs) from the non-coding regions of different genomes has been leading
this thought recently. The coding potential of these newly identified sORFs have been investigated through experimental and
computational approaches in recent studies. In the present work we have tried to make peptides from intergenic sequences of D.
melanogaster genome leading to therapeutic applications. Towards this goal of making novel peptides from non-coding genome, we
have found strong computational evidence of 145 peptides with conformational stability from the intergenic sequences of D.
melanogaster. The structure of these completely unique peptides was predicted using ab initio method. The function annotation of these
peptides was carried out using this structural information. The newly generated proteins were categorised as DNA/Protein/ion
binding proteins, electron transporters and a very few as enzymes too. Experimental studies can certainly provide validations to these
preliminary findings. This work provides further evidence of untapped potential of non-coding genome.
Collapse
Affiliation(s)
- Varughese Deepthi
- Department of Computational Biology and Bioinformatics, University of Kerala, Kariyavattom, Trivandrum
| | - Vineetha V I Nair
- Indian Institute of Information Technology and Management, Kerala,Technopark, Trivandrum, India
| | - Vipin Thomas
- Department of Computational Biology and Bioinformatics, University of Kerala, Kariyavattom, Trivandrum
| | - Navya Raj
- Department of Computational Biology and Bioinformatics, University of Kerala, Kariyavattom, Trivandrum
| | - Shidhi P Ramakrishnan
- Department of Computational Biology and Bioinformatics, University of Kerala, Kariyavattom, Trivandrum
| | - Juveria Khan
- School of Biotechnology,Jawaharlal Nehru University, New Delhi 110067
| | - Monika Kaushik
- School of Biotechnology,Jawaharlal Nehru University, New Delhi 110067
| | - Pawan K Dhar
- Department of Computational Biology and Bioinformatics, University of Kerala, Kariyavattom, Trivandrum;; School of Biotechnology,Jawaharlal Nehru University, New Delhi 110067
| | - Achuthsankar S Nair
- Department of Computational Biology and Bioinformatics, University of Kerala, Kariyavattom, Trivandrum
| |
Collapse
|
27
|
Bains S, Staight S, Paul M, Pilgrim S, Hoosein M, Al-Attar M, Kaushik M. Axillary assessment in invasive lobular cancers. Int J Surg 2016. [DOI: 10.1016/j.ijsu.2016.08.108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
28
|
Verma R, Jaiswal H, Chauhan KS, Kaushik M, Tailor P. Cutting Edge: ACVRL1 Signaling Augments CD8α+ Dendritic Cell Development. J Immunol 2016; 197:1029-34. [PMID: 27421479 DOI: 10.4049/jimmunol.1501849] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/19/2015] [Accepted: 06/16/2016] [Indexed: 11/19/2022]
Abstract
Dendritic cells (DCs) are a collection of different subtypes, each of which is characterized by specific surface markers, gene-expression patterns, and distinct functions. Members of the IFN regulatory factor family play critical roles in DC development and functions. Recently, Irf8 was shown to activate TGF-β signaling, which led to exacerbated neuroinflammation in the experimental autoimmune encephalomyelitis mouse model. We analyzed the effect of Irf8 on TGF-β/bone morphogenetic protein pathway-specific genes in DCs and identified Acvrl1, a type I TGF-β superfamily receptor, as a gene strongly induced by Irf8 expression. Among various DC subtypes, Acvrl1 is differentially expressed in CD8α(+) DCs. ACVRL1 signaling augmented Irf8-directed classical CD8α(+) DC development. Irf8 expression is essential for plasmacytoid DC and CD8α(+) DC development, and this study demonstrates that ACVRL1 signaling plays a pivotal role whereby it suppresses plasmacytoid DC development while enhancing that of CD8α(+) DCs, thus contributing to DC diversity development.
Collapse
Affiliation(s)
- Rohit Verma
- Laboratory of Innate Immunity, National Institute of Immunology, New Delhi, Delhi 110067, India
| | - Hemant Jaiswal
- Laboratory of Innate Immunity, National Institute of Immunology, New Delhi, Delhi 110067, India
| | - Kuldeep Singh Chauhan
- Laboratory of Innate Immunity, National Institute of Immunology, New Delhi, Delhi 110067, India
| | - Monika Kaushik
- Laboratory of Innate Immunity, National Institute of Immunology, New Delhi, Delhi 110067, India
| | - Prafullakumar Tailor
- Laboratory of Innate Immunity, National Institute of Immunology, New Delhi, Delhi 110067, India
| |
Collapse
|
29
|
Bains S, Paul M, Staight S, Pilgrim S, Hoosein M, Al-Attar M, Kaushik M. Axillary assessment in invasive lobular cancers. Eur J Surg Oncol 2016. [DOI: 10.1016/j.ejso.2016.02.136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
30
|
|
31
|
Kaushik M, Kaul S, Wadhwa R, Urade Y. Identification of somnogenic component of ashwagandha (Withania somnifera) leaf. Sleep Med 2015. [DOI: 10.1016/j.sleep.2015.02.1520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
32
|
Rattay T, Manickavasagar T, Thompson L, Kaushik M, Shokuhi S. P077. Neoadjuvant chemotherapy for stage II and III breast cancer increases breast conservation in all intrinsic breast cancer subtypes. Eur J Surg Oncol 2015. [DOI: 10.1016/j.ejso.2015.03.115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
33
|
Orgill S, Sheldon A, Godwin J, Robinson T, Kaushik M. P178. The Breast Care Nurses role in a holistic approach to assessing elderly patients with a diagnosis of breast cancer in a dedicated clinic. Eur J Surg Oncol 2015. [DOI: 10.1016/j.ejso.2015.03.216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
34
|
Brown J, Bonnington D, Shokuhi S, Kaushik M. 31. Advanced Nurse Practitioners – New roles and outcomes in symptomatic breast clinic. Eur J Surg Oncol 2015. [DOI: 10.1016/j.ejso.2015.03.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
35
|
Affiliation(s)
- Monika Kaushik
- Breast Surgery Unit, University Hospitals of Leicester NHS Trust, Leicester, UK
| | | | | |
Collapse
|
36
|
Kaushik M, Knowles SCL, Webster JP. What makes a feline fatal in Toxoplasma gondii's fatal feline attraction? Infected rats choose wild cats. Integr Comp Biol 2014; 54:118-28. [PMID: 24907200 DOI: 10.1093/icb/icu060] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Toxoplasma gondii is an indirectly transmitted protozoan parasite, of which members of the cat family (Felidae) are the only definitive hosts and small mammals such as rats serve as intermediate hosts. The innate aversion of rodents to cat odor provides an obstacle for the parasite against successful predation by the feline definitive host. Previous research has demonstrated that T. gondii appears to alter a rat's perception of the risk of being preyed upon by cats. Although uninfected rats display normal aversion to cat odor, infected rats show no avoidance and in some cases even show attraction to cat odor, which we originally termed the "Fatal Feline Attraction." In this study, we tested for the first time whether the "Fatal Feline Attraction" of T. gondii-infected rats differed according to the type of feline odor used, specifically whether it came from domestic cats (Felis silvestris catus) or wild cats-cheetahs (Acinonyx jubatus) or pumas (Felis concolor). In two-choice odor trials, where wild and domestic cat odors were competed against one another, consistent with previous findings we demonstrated that infected rats spent more time in feline odor zones compared with uninfected rats. However, we further demonstrated that all cat odors are not equal: infected rats had a stronger preference for wild cat odor over that of domestic cats, an effect that did not differ significantly according to the type of wild cat odor used (cheetah or puma). We discuss these results in terms of the potential mechanism of action and their implications for the current and evolutionary role of wild, in addition to domestic, cats in transmission of T. gondii.
Collapse
Affiliation(s)
- M Kaushik
- Department of Infectious Disease Epidemiology, School of Public Health, Imperial College Faculty of Medicine, St Mary's Campus, London W2 1PG, UK
| | - S C L Knowles
- Department of Infectious Disease Epidemiology, School of Public Health, Imperial College Faculty of Medicine, St Mary's Campus, London W2 1PG, UK
| | - J P Webster
- Department of Infectious Disease Epidemiology, School of Public Health, Imperial College Faculty of Medicine, St Mary's Campus, London W2 1PG, UK
| |
Collapse
|
37
|
Gill R, Chahar P, Kaushik M. Comprehensive genome-wide analysis of WDR superfamily of Plasmodium falciparum, cloning and production of PfWDR protein involved in chromatin remodelling. Int J Infect Dis 2014. [DOI: 10.1016/j.ijid.2014.03.455] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
38
|
Saunders D, Jones M, Kaushik M, Thomas WM. Fish bone perforation of the terminal ileum presenting as acute appendicitis. BMJ Case Rep 2014; 2014:bcr-2013-009533. [PMID: 24639331 DOI: 10.1136/bcr-2013-009533] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023] Open
Abstract
We report a case of a bowel perforation due to a fish bone that presented as an acute abdomen. This patient's gastrointestinal perforation was treated with laparoscopic and open technique. Diagnosis can be difficult as foreign body bowel perforation can mimic other causes of acute abdomen. Diagnosis is still most commonly made intraoperatively. Laparoscopy proved useful in this case as it allowed the most appropriate surgical approach to be made.
Collapse
|
39
|
Mathad VU, Singh H, Singh D, Butte MV, Kaushik M. Large primary intraorbital hydatid cyst in elderly. Asian J Neurosurg 2014; 8:163. [PMID: 24403962 PMCID: PMC3877506 DOI: 10.4103/1793-5482.121691] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
We report a case of solitary, primary intraorbital hydatid cyst in a elderly female aged 80 years who presented with nontender, nonpulsatile proptosis of left eye with diminution of vision. MRI scan of the head and the orbits, revealed a retro-bulbar cyst. Surgical excision was performed by employing a lateral orbitotomy approach. Histopathology report confirmed hydatid cyst.
Collapse
Affiliation(s)
- Veeresh U Mathad
- Department of Neurosurgery, Maulana Azad Medical College and G.B. Pant Hospital, New Delhi, India
| | - Hukum Singh
- Department of Neurosurgery, Maulana Azad Medical College and G.B. Pant Hospital, New Delhi, India
| | - Daljit Singh
- Department of Neurosurgery, Maulana Azad Medical College and G.B. Pant Hospital, New Delhi, India
| | - Manoj V Butte
- Department of Neurosurgery, Maulana Azad Medical College and G.B. Pant Hospital, New Delhi, India
| | - M Kaushik
- Department of Pathology, Maulana Azad Medical College and G.B. Pant Hospital, New Delhi, India
| |
Collapse
|
40
|
Saxena G, Singh D, Kaushik M. RMF+BCS Description of Some Traditional Neutron Magic Isotones. EPJ Web of Conferences 2014. [DOI: 10.1051/epjconf/20146602095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
41
|
Jaiswal H, Kaushik M, Sougrat R, Gupta M, Dey A, Verma R, Ozato K, Tailor P. Batf3 and Id2 have a synergistic effect on Irf8-directed classical CD8α+ dendritic cell development. J Immunol 2013; 191:5993-6001. [PMID: 24227775 DOI: 10.4049/jimmunol.1203541] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Dendritic cells (DCs) are heterogeneous cell populations represented by different subtypes, each varying in terms of gene expression patterns and specific functions. Recent studies identified transcription factors essential for the development of different DC subtypes, yet molecular mechanisms for the developmental program and functions remain poorly understood. In this study, we developed and characterized a mouse DC progenitor-like cell line, designated DC9, from Irf8(-/-) bone marrow cells as a model for DC development and function. Expression of Irf8 in DC9 cells led to plasmacytoid DCs and CD8α(+) DC-like cells, with a concomitant increase in plasmacytoid DC- and CD8α(+) DC-specific gene transcripts and induction of type I IFNs and IL12p40 following TLR ligand stimulation. Irf8 expression in DC9 cells led to an increase in Id2 and Batf3 transcript levels, transcription factors shown to be important for the development of CD8α(+) DCs. We show that, without Irf8, expression of Id2 and Batf3 was not sufficient for directing classical CD8α(+) DC development. When coexpressed with Irf8, Batf3 and Id2 had a synergistic effect on classical CD8α(+) DC development. We demonstrate that Irf8 is upstream of Batf3 and Id2 in the classical CD8α(+) DC developmental program and define the hierarchical relationship of transcription factors important for classical CD8α(+) DC development.
Collapse
Affiliation(s)
- Hemant Jaiswal
- Laboratory of Innate Immunity, National Institute of Immunology, New Delhi 110067, India
| | | | | | | | | | | | | | | |
Collapse
|
42
|
Thake M, Shokuhi S, Kaushik M. VTE prophylaxis for breast surgery; A prospective audit. Int J Surg 2013. [DOI: 10.1016/j.ijsu.2013.06.107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
43
|
Srinivasan S, Vyas N, Gupta A, Singh B, Kaushik M. Adsorption Behaviour of Diisopropyl Flourophosphate on Whetlerite Carbon. DEFENCE SCI J 2013. [DOI: 10.14429/dsj.63.2512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
44
|
Rattay T, Kaushik M, Ahmed S, Shokuhi S. Abstract P1-14-15: Recent experience of neoadjuvant chemotherapy according to breast cancer subtype: experience from a large United Kindgom teaching hospital. Cancer Res 2012. [DOI: 10.1158/0008-5472.sabcs12-p1-14-15] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
INTRODUCTION: The most recent United Kingdom (NICE, 2009) guidelines recommend neoadjuvant chemotherapy as the most appropriate initial treatment for locally advanced breast cancer followed by mastectomy. Neoadjuvant chemotherapy should also be offered to patients with early breast cancer who are considering breast conserving surgery that is not advisable at presentation. However, the evidence base is still gathering. This study reviews the recent experience of neoadjuvant chemotherapy in a large United Kingdom breast unit according to breast cancer subtype.
METHODS: Retrospective chart review of patients who received neoadjuvant chemotherapy for breast cancer at University Hospitals of Leicester between January 2008 and March 2011. Patients were identified from the unit database. Breast cancers were typed according to immunehistochemical marker profile: luminal A (ER or PR positive, HER2 negative), luminal B (ER or PR positive, HER2 positive), triple negative (ER and PR negative, HER2 negative), and HER2 positive (ER and PR negative, HER2 positive).
RESULTS: Of 2,489 new patients with breast cancer seen during the study period, 153 patients received neoadjuvant chemotherapy. 20 patients had lobular-type cancers, and the remaining 133 patients had ductal- or mixed-type histology. 101 patients had locally advanced disease and 52 patients presented as early breast cancer. 24 of all patients (15 %) achieved complete pathological response. 18 patients (12 %) never proceeded to surgery, eight of whom died during the study period. In total to date, 23 patients (15 %) have died including one death due to complications from chemotherapy. Of 120 patients initially scheduled for mastectomy, the tumor was downsized in 26 patients (22 %) so that they were able to undergo breast conserving surgery (BCS), with margins involved in six patients. The outcome of neoadjuvant chemotherapy according to breast cancer subtype is presented (Tables 1 and 2).
CONCLUSIONS: In our experience, patients receive neoadjuvant chemotherapy for breast cancer for a variety of indications. Compared to our standard population of breast cancer patients, early mortality remains relatively high, particlularly in the hormone receptor negative subtypes. BCS conversion rates were similar across breast cancer subtypes, but BCS was less likely to be successful in the Luminal A group. Luminal A cancers were also significantly less likely to achieve pCR after neoadjuvant chemotherapy. Breast cancer subtype should be taken into account when scheduling patients for neoadjuvant chemotherapy.
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P1-14-15.
Collapse
Affiliation(s)
- T Rattay
- University Hospitals of Leicester, United Kingdom
| | - M Kaushik
- University Hospitals of Leicester, United Kingdom
| | - S Ahmed
- University Hospitals of Leicester, United Kingdom
| | - S Shokuhi
- University Hospitals of Leicester, United Kingdom
| |
Collapse
|
45
|
Gok Oguz E, Olmaz R, Turgutalp K, Muslu N, Sungur MA, Kiykim A, Van Biesen W, Vanmassenhove J, Glorieux G, Vanholder R, Chew S, Forster K, Kaufeld T, Kielstein J, Schilling T, Haverich A, Haller H, Schmidt B, Hu P, Liang X, Liang X, Chen Y, LI R, Jiang F, LI Z, Shi W, Lim CCW, Lim CCW, Chia CML, Tan AK, Tan CS, Hu P, Liang X, Liang X, Chen Y, LI R, Jiang F, LI Z, Shi W, Ng R, Subramani S, Chew S, Perez de Jose A, Bernis Carro C, Madero Jarabo R, Bustamante J, Sanchez Tomero JA, Chung W, Ro H, Chang JH, Lee HH, Jung JY, Vanmassenhove J, Van Biesen W, Glorieux G, Vanholder R, Fazzari L, Giuliani A, Scrivano J, Pettorini L, Benedetto U, Luciani R, Roscitano A, Napoletano A, Coclite D, Cordova E, Punzo G, Sinatra R, Mene P, Pirozzi N, Shavit L, Shavit L, Manilov R, Algur N, Wiener-Well Y, Slotki I, Pipili C, Pipili C, Vrettou CS, Avrami K, Economidou F, Glynos K, Ioannidou S, Markaki V, Douka E, Nanas S, De Pascalis A, De Pascalis A, Cofano P, Proia S, Valletta A, Vitale O, Russo F, Buongiorno E, Filiopoulos V, Biblaki D, Lazarou D, Chrysis D, Fatourou M, Lafoyianni S, Vlassopoulos D, Zakiyanov O, Kriha V, Vachek J, Svarcova J, Zima T, Tesar V, Kalousova M, Kaushik M, Kaushik M, Ronco C, Cruz D, Zhang L, Zhang W, Zhang W, Chen N, Ejaz AA, Kambhampati G, Ejaz N, Dass B, Lapsia V, Arif AA, Asmar A, Shimada M, Alsabbagh M, Aiyer R, Johnson R, Chen TH, Chang CH, Chang MY, Tian YC, Hung CC, Fang JT, Yang CW, Chen YC, Cantaluppi V, Quercia AD, Figliolini F, Giacalone S, Pacitti A, Gai M, Guarena C, Leonardi G, Leonardi G, Biancone L, Camussi G, Segoloni GP, De Cal M, Lentini P, Clementi A, Virzi GM, Scalzotto E, Ronco C, Lacquaniti A, Lacquaniti A, Donato V, Fazio MR, Lucisano S, Cernaro V, Lupica R, Buemi M, Turgutalp K, Helvaci I, Anik E, Kiykim A, Wani M, Wani DI, Bhat DMA, Banday DK, Najar DMS, Reshi DAR, Palla DNA, Turgutalp K, Kiykim A, Helvaci I, Iglesias P, Olea T, Vega-Cabrera C, Heras M, Bajo MA, Del Peso G, Arias MJ, Selgas R, Diez JJ, Daher E, Costa PL, Pereira ENS, Santos RDP, Abreu KL, Silva Junior G, Pereira EDB, Raimundo M, Crichton S, Syed Y, Martin J, Whiteley C, Bennett D, Ostermann M, Gjyzari A, Thereska N, Koroshi A, Barbullushi M, Kodra S, Idrizi A, Strakosha A, Petrela E, Raimundo M, Crichton S, Syed Y, Martin J, Lemmich Smith J, Bennett D, Ostermann M, Klimenko A, Tuykhmenev E, Villevalde S, Kobalava Z, Avdoshina S, Villevalde S, Tyukhmenev E, Efremovtseva M, Kobalava Z, Hayashi H, Hayashi H, Suzuki S, Kataoka K, Kondoh Y, Taniguchi H, Sugiyama D, Nishimura K, Sato W, Maruyama S, Matsuo S, Yuzawa Y, Geraldine D, Muriel F, Alexandre H, Eric R, Fu P, Zhang L, Pozzato M, Ferrari F, Cecere P, Mesiano P, Vallero A, Livigni S, Quarello F, Hudier L, Decaux O, Haddj-Elmrabet A, Mandart L, Lino-Daniel M, Bridoux F, Renaudineau E, Sawadogo T, Le Pogamp P, Vigneau C, Famee D, Koo HM, Oh HJ, Han SH, Choi KH, Kang SW, Mehdi M, Nicolas M, Mariat C, Shah P, Kute VB, Vanikar A, Gumber M, Patel H, Trivedi H, Pipili C, Pipili C, Manetos C, Vrettou CS, Poulaki S, Tripodaki ES, Papastylianou A, Routsi C, Nanas S, Uchida K, Kensuke U, Yamagata K, Saitou C, Okada M, Chita G, Davies M, Veriawa Y, Naicker S, Mukhopadhyay P, Mukherjee D, Mishra R, Kar M, Zickler D, Wesselmann H, Schindler R, Gutierrez* E, Egido J, Rubio-Navarro A, Buendia I, Blanco-Colio LM, Toldos O, Manzarbeitia F, De Lorenzo A, Sanchez R, Praga^ M, Moreno^ JA, Kim MY, Kang NR, Jang HR, Lee JE, Huh W, Kim YG, Kim DJ, Hong SC, Kim JS, Oh HY, Okamoto T, Kamata K, Naito S, Tazaki H, Kan S, Anne-Kathrin LG, Matthias K, Speer T, Andreas L, Heinrich G, Thomas V, Poppleton A, Danilo F, Matthias K, Lai CF, Wu VC, Shiao CC, Huang TM, Wu KD, Bedford M, Farmer C, Irving J, Stevens P, Patera F, Patera F, Mattozzi F, Battistoni S, Fagugli RM, Park MY, Choi SJ, Kim JG, Hwang SD, Xie H, Chen H, Xu S, He Q, Liu J, Hu W, Liu Z, Dalboni M, Blaya R, Quinto BM, Narciso R, Oliveira M, Monte J, Durao M, Cendoroglo M, Batista M, Hanemann AL, Liborio A, Daher E, Martins A, Pinheiro MCC, Silva Junior G, Meneses G, De Paula Pessoa R, Sousa M, Bezerra FSM, Albuquerque PLMM, Lima JB, Lima CB, Veras MDSB, Silva Junior G, Daher E, Nemoto Matsui T, Totoli C, Cruz Andreoli MC, Vilela Coelho MP, Guimaraes de Souza NK, Ammirati AL, De Carvalho Barreto F, Ferraz Neto BH, Fortunato Cardoso Dos Santos B, Abraham A, Abraham G, Mathew M, Duarte PMA, Duarte FB, Barros EM, Castro FQS, Silva Junior G, Daher E, Palomba H, Castro I, Sousa SR, Jesus AN, Romano T, Burdmann E, Yu L, Kwon SH, You JY, Hyun YK, Woo SA, Jeon JS, Noh HJ, Han DC, Tozija L, Tozija L, Petronievic Z, Selim G, Nikolov I, Stojceva-Taneva O, Cakalaroski K, Lukasz A, Beneke J, Schmidt B, Kielstein J, Haller H, Menne J, Schiffer M, Polanco N, Hernandez E, Gutierrez E, Gutierrez Millet V, Gonzalez Monte E, Morales E, Praga M, Francisco Javier L, Nuria GF, Jose Maria MG, Bes Rastrollo M, Angioi A, Conti M, Cao R, Atzeni A, Pili G, Matta V, Murgia E, Melis P, Binda V, Pani A, Thome* F, Leusin F, Barros E, Morsch C, Balbinotto A, Pilla C, Premru V, Buturovic-Ponikvar J, Ponikvar R, Marn-Pernat A, Knap B, Kovac J, Gubensek J, Kersnic B, Krnjak L, Prezelj M, Granatova J, Havrda M, Hruskova Z, Kratka K, Remes O, Mokrejsova M, Bolkova M, Lanska V, Rychlik I, Uniacke MD, Lewis RJ, Harris S, Roderick P, Thome* F, Balbinotto A, Barros E, Morsch C, Martin N, Ulrich K, Jan B, Jorn B, Reinhard B, Jan K, Hermann H, Meyer Tobias F, Leyla R, Schmidt Bernhard MW, Harald S, Jurgen S, Tanja K, Menne J, Mario S, Jan B, Jan B, Sang Hi E, Leyla R, Claus M, Frank V, Aleksej S, Sengul S, Jan K, Jorn B, Reinhard B, Meyer Tobias F, Schmidt Bernhard MW, Mario S, Martin N, Ulrich K, Robert S, Karin W, Tanja K, Hermann H, Menne J, Leyla R, Leyla R, Jan K, Jan B, Reinhard B, Feikah G, Hermann H, Tanja K, Ulrich K, Menne Tobias F, Claus M, Martin N, Mario S, Schmidt Bernhard MW, Harald S, Jurgen S, Menne J, Claus M, Claus M, Jan K, Jan B, Reinhard B, Feikah G, Hermann H, Ulrich K, Menne Tobias F, Meyer Tobias N, Martin N, Leyla R, Schmidt Bernhard MW, Harald S, Jurgen S, Tanja K, Mario S, Menne J, Kielstein J, Beutel G, Fleig S, Steinhoff J, Meyer T, Hafer C, Bramstedt J, Busch V, Vischedyk M, Kuhlmann U, Ries W, Mitzner S, Mees S, Stracke S, Nurnberger J, Gerke P, Wiesner M, Sucke B, Abu-Tair M, Kribben A, Klause N, Schindler R, Merkel F, Schnatter S, Dorresteijn E, Samuelsson O, Brunkhorst R, Stec-Hus Registry G, Reising A, Hafer C, Kielstein J, Schmidt B, Bange FC, Hiss M, Vetter F, Kielstein J, Beneke J, Bode-Boger SM, Martens-Lobenhoffer J, Schiffer M, Schmidt BMW, Haller H, Menne J, Kielstein JT, Shin HS, Jung YS, Rim H. AKI - Clinical. Nephrol Dial Transplant 2012. [DOI: 10.1093/ndt/gfs235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
46
|
Kaushik M, Rattay T, Shokuhi S. Management of human epidermal growth factor receptor-2 (HER2) positive breast cancer patients at University Hospitals of Leicester. Eur J Surg Oncol 2012. [DOI: 10.1016/j.ejso.2012.02.138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
47
|
Liu J, Liu J, Liu Y, Xu Y, Zhao X, Qian J, Sun B, Xing C, Kanda R, Hamada C, Nakano T, Wakabayashi K, Io H, Horikoshi S, Tomino Y, Ishimatsu N, Miyamoto T, Morimoto H, Nakamata J, Baba R, Kanegae K, Serino R, Kabashima N, Otsuji Y, Doi Y, Tamura M, Nakamata J, Morimoto H, Baba R, Ishimatsu N, Miyamoto T, Kanegae K, Serino R, Kabashima N, Otsuji Y, Doi Y, Tamura M, Kusumoto T, Fukami K, Yamagishi SI, Ueda S, Kaida Y, Hazama T, Nakayama Y, Ando R, Obara N, Okuda S, Tamura M, Matsumoto M, Miyamoto T, Kanegae K, Furuno Y, Serino R, Kabashima N, Otsuji Y, Bang-Gee H, Mazzotta L, Rosati A, Carlini A, Henriques VT, Zangiacomi Martinez E, Divino-Filho JC, Pecoits-Filho R, Cardeal Da Costa JA, Henriques VT, Henriques VT, Gama Axelsson T, Lindholm B, Carrero JJ, Heimburger O, Stenvinkel P, Qureshi AR, Akazawa M, Uno T, Kanda E, Maeda Y, Aktsiali M, Aktsiali M, Antonopoulou S, Tsiolaki K, Bakirtzi N, Patrinou A, Georgopoulou M, Liaveri P, Afentakis N, Tsirpanlis G, Hasegawa T, Nishiwaki H, Hirose M, Komukai D, Tayama H, Koiwa F, Yoshimura A, Lui SL, Lui S, Yung S, Tang C, Ng F, Lo WK, Chan TM, Koo HM, Doh FM, Yoo DE, Oh HJ, Yoo TH, Choi KH, Kang SW, Han DS, Han SH, Fernandes N, Fernandes N, Bastos MG, Gianotti Franco MR, Chaoubah A, Gloria Lima MD, Pecoits-Filho R, Divino-Filho JC, Qureshi AR, Kang S, Do J, Cho K, Park J, Yoon K, Chen JB, Cheng BC, Chen TC, Su YJ, Wu CH, Park Y, Jeon J, Tsikeloudi M, Pateinakis P, Patsatsi K, Manou E, Sotiriadis D, Tsakiris D, Teixeira L, Rodrigues A, Carvalho MJ, Cabrita A, Mendonca D, Kang S, Do J, Park J, Cho K, Yoon K, Bruschi M, Candiano G, Santucci L, Luzio S, Cannavo R, Ghiggeri GM, Verrina E, Varadarajan Y, Raju B, Cho KH, Do J, Kang S, Park JW, Yoon KW, Kim TW, Kimmel M, Braun N, Latus J, Alscher MD, Struijk D, Van Esch S, Krediet RT, Fernandes N, Van den Beukel T, Hoekstra T, Tirapani L, De Andrade Bastos K, Pecoits-Filho R, Qureshi AR, Bastos M, Dekker F, Divino-Filho JC, Yasuhisa T, Kanai H, Harada K, Kawai Y, Sugiyama H, Ito Y, Tsuruya K, Yoshida H, Maruyama H, Goto S, Nakayama M, Nakamoto H, Morinaga H, Matsuo S, Makino H, DI Gioia MC, Gallar P, Laso N, Rodriguez I, Cobo G, Oliet A, Hynostroza J, Herrero JC, Mon C, Ortiz M, Vigil A, Tomo T, Portoles J, Uta S, Uta S, Tato AM, Lopez-Sanchez P, Rivera M, Rodriguez-Pena R, Del Peso G, Ortega M, Felipe C, Tsampikaki E, Aperis G, Kaikis A, Paliouras C, Karvouniaris N, Maragaki M, Alivanis P, Kortus-Gotze B, Hoferhusch T, Hoyer J, Martino F, Kaushik M, Rodighiero MP, Creapldi C, Ronco C, Lacquaniti A, Lacquaniti A, Donato V, Fazio MR, Lucisano S, Cernaro V, Lupica R, Buemi M, Aloisi C, Uno T, Akazawa M, Kanda E, Maeda Y, Bavbek Ruzgaresen N, Secilmis S, Yilmaz H, Akcay A, Duranay M, Akalin N, Akalin N, Altiparmak MR, Trabulus S, Yalin AS, Ataman R, Serdengecti K, Schneider K, Bator B, Niko B, Braun N, Peter F, Ulmer C, Joerg L, Martin K, Dagmar B, German O, Fabian R, Juergen D, Stephan S, Dominik A, Latus J, Latus J, Ulmer C, Fritz P, Rettenmaier B, Hirschburger S, Segerer S, Biegger D, Lang T, Ott G, Kimmel M, Alscher MD, Braun N, Habib M, Korte M, Hagen M, Dor F, Betjes M, Habib M, Hagen M, Korte M, Zietse R, Dor F, Betjes M, Latus J, Latus J, Ulmer C, Fritz P, Rettenmaier B, Biegger D, Lang T, Ott G, Scharpf C, Kimmel M, Alscher MD, Braun N, Habib M, Korte M, Zietse R, Betjes M, Chang TI, Shin DH, Oh HJ, Kang SW, Han DS, Yoo TH, Han SH, Choi HY, Lee YK, Kim BS, Han SH, Yoo TH, Park HC, Lee HY, Horimoto N, Tuji K, Kitamura S, Sugiyama H, Makino H, Isshiki R, Isshiki R, Iwagami M, Tsutsumi D, Mochida Y, Ishioka K, Oka M, Maesato K, Moriya H, Ohtake T, Hidaka S, Kobayashi S, Higuchi C, Tanihata Y, Ishii M, Sugimoto H, Sato N, Kyono A, Ogawa T, Nishimura H, Otsuka K, Cho KH, Do JY, Kang S, Park JW, Yoon KW, Kim TW, Du Halgouet C, Latifa A, Anne Sophie V, Emmanuel D, Christine R, Francois V, Grzelak T, Czyzewska-Majchrzak L, Kramkowska M, Witmanowski H, Czyzewska K, Janda K, Krzanowski M, Dumnicka P, Sulowicz W, Rroji M, Seferi S, Barbullushi M, Likaj E, Petrela E, Thereska N, Cabiddu G, Dessi E, Arceri A, Laura P, Manca E, Conti M, Cao R, Pani A, Liao CT, Vega Vega O, Mendoza de la Garza A, Correa-Rotter R, Ueda A, Nagai K, Morimoto M, Hirayama A, Owada S, Tonozuka Y, Saito C, Saito C, Yamagata K, Matsuda A, Tayama Y, Ogawa T, Iwanaga M, Noiri C, Hatano M, Kiba T, Kanozawa K, Katou H, Hasegawa H, Mitarai T, Ros-Ruiz S, Ros-Ruiz S, Fuentes-Sanchez L, Jironda-Gallegos C, Gutierrez-Vilches E, Garcia-Frias P, Hernandez-Marrero D, Kang S, Lee S, Cho K, Park J, Yoon K, Do J, Lai X, Chen W, Guo Z, Braide M, Cristina V, Popa SG, Maria M, Eugen M, Martino F, DI Loreto P, DI Loreto P, Ronco C, Rroji M, Seferi S, Barbullushi M, Petrela E, Spahia N, Likaj E, Thereska N, Sanchez Macias LO, Sanchez Macias LO, Lares Castellanos KI, Hernandez Pacheco JA, Vega Vega O, Correa Rotter R, Pedro Ventura A, Olivia S, Teixeira L, Joana V, Francisco F, Maria Joao C, Antonio C, Rodrigues AS, Atas N, Erten Y, Erten Y, Onec K, Inal S, Topal S, Akyel A, Celik B, Okyay GU, Tavil Y, Zeiler M, Monteburini T, Agostinelli RM, Marinelli R, Santarelli S, Erten Y, Erten Y, Inal S, Onec K, Atas N, Okyay GU, Yaylaci C, Sahin G, Tavil Y, Guz G, Sindel S, Pinho A, Cabrita A, Malho Guedes A, Fragoso A, Carreira H, Pinto I, Bernardo I, Leao P, Janda K, Janda K, Krzanowski M, Kusnierz-Cabala B, Dumnicka P, Krasniak A, Chowaniec E, Tabor-Ciepiela B, Sulowicz W, Turkmen K, Ozbek O, Kayrak M, Samur C, Guler I, Tonbul HZ, Rusai K, Herzog R, Kratochwill K, Kuster L, Aufricht C, Meier CM, Fliser D, Schilling MK, Klingele M, Fukasawa M, Fukasawa M, Takeda M, Kamiyama M, Song YR, Kim HJ, Kim SG, Kim JK, Noh JW, Lee YK, Yoon JW, Koo JR. Peritoneal dialysis. Nephrol Dial Transplant 2012. [DOI: 10.1093/ndt/gfs243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
48
|
Kaushik M, Shokuhi S. 94 Male Breast Cancer – University Hospitals of Leicester Experience. Eur J Cancer 2012. [DOI: 10.1016/s0959-8049(12)70162-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
49
|
Kaushik M, Rattay T, Shokuhi S. 185 Management of Human Epidermal Growth Factor Receptor-2(HER2) Positive Breast Cancer Patients at University Hospitals of Leicester. Eur J Cancer 2012. [DOI: 10.1016/s0959-8049(12)70253-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
50
|
Kaushik M, Michalakis I, Krupa J. 543 Initial Experience with the Use of Porcine Acellular Dermal Matrix for Breast Reconstruction. Eur J Cancer 2012. [DOI: 10.1016/s0959-8049(12)70608-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|